This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Vitrisa Therapeutics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Renta Hutabarat: Innovator in Retinal Disease Treatment
Introduction
Renta Hutabarat is a notable inventor based in Dracut, MA (US). She has made significant contributions to the field of retinal disease treatment through her innovative research and development.
Latest Patents
Renta holds a patent for "Compositions with improved intravitreal half-life and uses thereof." This patent outlines compositions and methods designed for the treatment of retinal diseases. The innovative compositions include a therapeutic agent that is conjugated to a vitreous component binding moiety. This binding moiety can be an aptamer or a small molecule that specifically binds to structural components of the vitreous humor, such as hyaluronic acid, collagen, or vitronectin. Renta has 1 patent to her name.
Career Highlights
Renta Hutabarat is currently associated with Vitrisa Therapeutics, Inc., where she continues to advance her research in retinal therapies. Her work is pivotal in developing new treatment options for patients suffering from retinal diseases.
Collaborations
Renta collaborates with esteemed colleagues, including Carl Erickson and Christopher P. Rusconi, to further enhance the impact of her research.
Conclusion
Renta Hutabarat is a pioneering inventor whose work in retinal disease treatment is making a significant difference in the medical field. Her innovative approaches and collaborations are paving the way for future advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile